new risk calculator for heart failure
secondary analysis of a large trial of patients with heart failure with preserved ejection fraction found that a predictive model (PREDICT-HFpEF) was quite accurate in predicting actual events that occurred (see chf PREDICT finerenone study JAMAcardiol2025 , or doi:10.1001/jamacardio.2025.0025) Details : -- 6001 patients were enrolled in the FINEARTS study that found that finerenone, a nonsteroidal mineralocorticoid receptor antagonist that is more selective than spironolactone, had the same benefit as spironolactone in patients with heart failure with preserved ejection fraction (HFpEF), reducing the rate of unplanned hospital admissions or urgent visits for heart failure by 16% over placebo, independent of the use of SGLT-2 inhibitors: https://www.nejm.org/doi/full/10.1056/NEJMoa2407107 --the FINEARTS study was performed across 653 sites in 37 countries in adults who were at least 40 years old and had symptomatic heart failure; left ventri...